T. Rowe Price [TROW] vs Raymond James [RJF] Detailed Stock Comparison
T. Rowe Price
NASDAQ
Loading...
Raymond James
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: T. Rowe Price wins in 9 metrics, Raymond James wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | T. Rowe Price | Raymond James | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.71 | 16.07 | T. Rowe Price |
| Price-to-Book Ratio | 2.18 | 2.93 | T. Rowe Price |
| Debt-to-Equity Ratio | 4.42 | 36.49 | T. Rowe Price |
| PEG Ratio | 11.18 | 14.98 | T. Rowe Price |
| EV/EBITDA | 7.90 | N/A | N/A |
| Profit Margin (TTM) | 28.72% | 16.14% | T. Rowe Price |
| Operating Margin (TTM) | 27.75% | 20.38% | T. Rowe Price |
| EBITDA Margin (TTM) | 27.75% | 20.38% | T. Rowe Price |
| Return on Equity | 18.72% | 18.87% | Raymond James |
| Return on Assets (TTM) | 10.36% | 2.66% | T. Rowe Price |
| Free Cash Flow (TTM) | $1.26B | $1.95B | Raymond James |
| Dividend Yield | 5.84% | 0.94% | T. Rowe Price |
| 1-Year Return | -1.21% | 41.51% | Raymond James |
| Price-to-Sales Ratio (TTM) | 3.24 | 2.48 | Raymond James |
| Enterprise Value | $21.68B | $21.77B | Raymond James |
| EV/Revenue Ratio | 3.06 | 1.61 | Raymond James |
| Gross Profit Margin (TTM) | 48.06% | N/A | N/A |
| Revenue per Share (TTM) | $32 | $66 | Raymond James |
| Earnings per Share (Diluted) | $8.93 | $10.38 | Raymond James |
| Beta (Stock Volatility) | 1.49 | 1.04 | Raymond James |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
T. Rowe Price vs Raymond James Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| T. Rowe Price | -0.77% | 1.17% | 1.74% | 14.64% | 1.61% | -4.53% |
| Raymond James | 0.38% | 1.19% | 2.90% | 12.84% | 8.96% | 6.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| T. Rowe Price | -1.21% | -9.52% | -22.16% | 49.57% | 139.37% | 237.56% |
| Raymond James | 41.51% | 54.78% | 223.11% | 363.85% | 931.65% | 1,159.68% |
Performance & Financial Health Analysis: T. Rowe Price vs Raymond James
| Metric | TROW | RJF |
|---|---|---|
| Market Information | ||
| Market Cap | $22.97B | $33.66B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,102,110 | 1,312,677 |
| 90 Day Avg. Volume | 1,610,037 | 1,160,739 |
| Last Close | $107.46 | $165.90 |
| 52 Week Range | $77.85 - $125.81 | $113.91 - $174.32 |
| % from 52W High | -14.59% | -4.83% |
| All-Time High | $224.56 (Aug 30, 2021) | $174.32 (Jan 27, 2025) |
| % from All-Time High | -52.15% | -4.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.11% |
| Quarterly Earnings Growth | 0.05% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.16% |
| Operating Margin (TTM) | 0.28% | 0.20% |
| Return on Equity (TTM) | 0.19% | 0.19% |
| Debt to Equity (MRQ) | 4.42 | 36.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $48.02 | $57.03 |
| Cash per Share (MRQ) | $13.92 | $75.54 |
| Operating Cash Flow (TTM) | $1.53B | $2.17B |
| Levered Free Cash Flow (TTM) | $811.14M | $2.06B |
| Dividends | ||
| Last 12-Month Dividend Yield | 5.84% | 0.94% |
| Last 12-Month Dividend | $6.29 | $1.40 |
Valuation & Enterprise Metrics Analysis: T. Rowe Price vs Raymond James
| Metric | TROW | RJF |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.71 | 16.07 |
| Forward P/E | 11.18 | 14.98 |
| PEG Ratio | 11.18 | 14.98 |
| Price to Sales (TTM) | 3.24 | 2.48 |
| Price to Book (MRQ) | 2.18 | 2.93 |
| Market Capitalization | ||
| Market Capitalization | $22.97B | $33.66B |
| Enterprise Value | $21.68B | $21.77B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.06 | 1.61 |
| Enterprise to EBITDA | 7.90 | N/A |
| Risk & Other Metrics | ||
| Beta | 1.49 | 1.04 |
| Book Value per Share (MRQ) | $48.02 | $57.03 |
Financial Statements Comparison: T. Rowe Price vs Raymond James
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TROW | RJF |
|---|---|---|
| Revenue/Sales | $1.72B | $3.35B |
| Cost of Goods Sold | $895.00M | N/A |
| Gross Profit | $828.30M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $509.50M | N/A |
| EBITDA | $481.90M | N/A |
| Pre-Tax Income | $713.80M | $671.00M |
| Income Tax | $157.70M | $176.00M |
| Net Income (Profit) | $556.10M | $495.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TROW | RJF |
|---|---|---|
| Cash & Equivalents | $2.84B | $9.66B |
| Total Current Assets | $3.77B | N/A |
| Total Current Liabilities | $642.20M | N/A |
| Long-Term Debt | $472.10M | $2.89B |
| Total Shareholders Equity | $11.53B | $12.23B |
| Retained Earnings | $10.24B | $12.77B |
| Property, Plant & Equipment | $1.42B | $1.22B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TROW | RJF |
|---|---|---|
| Operating Cash Flow | $713.90M | $248.00M |
| Capital Expenditures | $-82.00M | $-46.00M |
| Free Cash Flow | $550.90M | $71.00M |
| Debt Repayment | N/A | $-200.00M |
| Common Stock Repurchase | $-215.20M | $-274.00M |
Short Interest & Institutional Ownership Analysis
| Metric | TROW | RJF |
|---|---|---|
| Shares Short | 9.81M | 8.64M |
| Short Ratio | 5.57 | 7.01 |
| Short % of Float | 0.05% | 0.05% |
| Average Daily Volume (10 Day) | 1,102,110 | 1,312,677 |
| Average Daily Volume (90 Day) | 1,610,037 | 1,160,739 |
| Shares Outstanding | 222.97M | 203.29M |
| Float Shares | 214.58M | 179.49M |
| % Held by Insiders | 0.02% | 0.10% |
| % Held by Institutions | 0.81% | 0.79% |
Dividend Analysis & Yield Comparison: T. Rowe Price vs Raymond James
| Metric | TROW | RJF |
|---|---|---|
| Last 12-Month Dividend | $6.29 | $1.40 |
| Last 12-Month Dividend Yield | 5.84% | 0.94% |
| 3-Year Avg Annual Dividend | $5.35 | $1.55 |
| 3-Year Avg Dividend Yield | 1.15% | 0.38% |
| 3-Year Total Dividends | $16.05 | $4.66 |
| Ex-Dividend Date | Sep 15, 2025 | Jan 02, 2025 |